← Back to Search

Change in knowledge, motivation, skills, resources for Coronavirus Infection

N/A
Waitlist Available
Led By Mohsen Bazargan, PhD
Research Sponsored by Charles Drew University of Medicine and Science
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
African American older adults aged 55 years with a chronic medical condition or 65years and older
Have at least one risk factor for COVID-19
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial is testing an intervention to help African American adults manage chronic disease and social isolation, two major risk factors for COVID-19. The intervention involves partnering with African American churches to implement Federal and State guidelines aimed at preventing COVID-19 outbreaks, and training church-based health advisors to help parishioners manage their chronic health conditions and reduce psychological distress.

Eligible Conditions
  • Coronavirus Infection

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Participants Achieving Improvement of Health Conditions Using the Severity of Medical Chronic Conditions Surveys
Percentage of Participants Achieving Target Levels of Knowledge, Attitude, and Behaviors with NIH Toolbox Surveys
Prevalence of COVID-19 testing using Participant COVID-19 Test History Survey
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Risk Reduction of COVID-19 Among African American ParishionersExperimental Treatment1 Intervention
This arm will implement "one group pretest-posttest" design to improve COVID associated health outcomes of AA older parishioners in collaboration with trained young church-based health educators.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Change in knowledge, motivation, skills, resources
2021
N/A
~150

Find a Location

Who is running the clinical trial?

Charles Drew University of Medicine and ScienceLead Sponsor
51 Previous Clinical Trials
6,487 Total Patients Enrolled
Mohsen Bazargan, PhDPrincipal InvestigatorCharles R. Drew University of Medicine & Science
2 Previous Clinical Trials

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has a cap been set on the number of individuals who can enroll in this trial?

"Affirmative. According to the clinicaltrials.gov database, this medical investigation is presently searching for individuals who meet criteria. It was initially posted on June 1st 2021 and has since been revised as of January 31 2022. The trial requires 240 patients from just a single centre in order to reach completion."

Answered by AI

Is participation in this medical experiment still accessible to individuals?

"Affirmative. Clinicaltrials.gov reveals that this medical experiment began recruiting on June 1st 2021 and the most recent amendment to its details was made on January 31st 2022; it seeks 240 participants from a single site."

Answered by AI
~40 spots leftby Mar 2025